Shanghai ChemPartner appoints new VP and Head of Biology and Pharmacology

June 22, 2023 | Thursday | News

Dr Yin is a molecular biologist by training and possesses extensive experience in target discovery and validation

ChemPartner has announced the appointment of Yinfei Yin, Ph.D. as vice president of and head of the biology and pharmacology department at Shanghai ChemPartner.

Dr Yin brings a wealth of experience and expertise to his new role, having established himself as a highly accomplished scientist in both academia and the biopharmaceutical industry. With a PhD in oncology from the University of Nottingham, Dr Yin is a molecular biologist by training and possesses extensive experience in target discovery and validation, assay development, preclinical imaging, and advanced in vivo models.

Prior to joining ChemPartner, Dr Yin was the executive director and head of scientific operations (US/UK) and the global head of preclinical imaging at CrownBio for over 10 years.

As a leading, global CRO and CDMO, ChemPartner provides integrated life science services for drug discovery and development with expertise in discovery chemistry, biology, pharmacology, DMPK, exploratory toxicology, biologics discovery and development, and biologics manufacturing. 

 

Sign up for the editor pick and get articles like this delivered right to your inbox.

+Country Code-Phone Number(xxx-xxxxxxx)

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls